Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02555410 · ClinicalTrials.gov registry record
Seizure Detection and Warning System in Epilepsy Patients
A clinical trial of Epilepsy and Generalized Tonic-Clonic Seizures, sponsored by Brain Sentinel.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT02555410 is a study of Epilepsy and Generalized Tonic-Clonic Seizures that has completed, run by Brain Sentinel. The registered enrollment target is 11 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02555410, a study of Epilepsy and Generalized Tonic-Clonic Seizures, has completed, sponsored by Brain Sentinel.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a phase III, pilot, prospective study of an Electromyography (EMG) based seizure detection system for detecting Generalized Tonic-Clonic Seizures (GTCS) in the home.
Conditions Studied
Interventions
- DEVICE Brain Sentinel Seizure Detection and Warning System
Study Locations (1)
Texas
- Jose' E. Cavazos - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-01 |
| Est. Completion | 2017-07-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02555410
The ClinicalTrials.gov registry entry for NCT02555410 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (99% lower). The listed sponsor is Brain Sentinel, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Brain Sentinel Seizure Detection and Warning System is the first listed.
NCT02555410 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02555410 about?
NCT02555410 is a clinical study titled "Seizure Detection and Warning System in Epilepsy Patients". This is a phase III, pilot, prospective study of an Electromyography (EMG) based seizure detection system for detecting Generalized Tonic-Clonic Seizures (GTCS) in the home.
What is the current status of trial NCT02555410?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2013-01. Estimated completion is 2017-07-07.
What conditions does trial NCT02555410 study?
This clinical trial studies the following conditions: Epilepsy, Generalized Tonic-Clonic Seizures.
What interventions are being tested in trial NCT02555410?
The interventions under investigation include: Brain Sentinel Seizure Detection and Warning System (DEVICE).
Who is sponsoring clinical trial NCT02555410?
This trial is sponsored by Brain Sentinel, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02555410 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.